111 related articles for article (PubMed ID: 8393423)
1. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells.
Yano H; Iemura A; Fukuda K; Mizoguchi A; Haramaki M; Kojiro M
Hepatology; 1993 Aug; 18(2):320-7. PubMed ID: 8393423
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 in human hepatocellular carcinoma cell lines.
Haramaki M; Yano H; Fukuda K; Momosaki S; Ogasawara S; Kojiro M
Hepatology; 1995 May; 21(5):1276-84. PubMed ID: 7537711
[TBL] [Abstract][Full Text] [Related]
3. A new human hepatocellular carcinoma cell line (HAK-2) forms various structures in collagen gel matrices.
Haramaki M; Yano H; Iemura A; Momosaki S; Ogasawara S; Inoue M; Yamaguchi R; Kusaba A; Utsunomiya I; Kojiro M
Hum Cell; 1997 Sep; 10(3):183-92. PubMed ID: 9436038
[TBL] [Abstract][Full Text] [Related]
4. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
[TBL] [Abstract][Full Text] [Related]
5. High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
Aishima S; Basaki Y; Oda Y; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Hosoi F; Maruyama Y; Fotovati A; Oie S; Ono M; Ueno T; Sata M; Yano H; Kojiro M; Kuwano M; Tsuneyoshi M
Cancer Sci; 2006 Nov; 97(11):1182-90. PubMed ID: 16965600
[TBL] [Abstract][Full Text] [Related]
6. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution.
Chiu JH; Chang HM; Kao HL; Wu LH; Lui WY
Cancer Detect Prev; 1996; 20(1):43-51. PubMed ID: 8907202
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
Ariizumi S; Takasaki K; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S
Hepatogastroenterology; 2004; 51(56):500-4. PubMed ID: 15086191
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
[TBL] [Abstract][Full Text] [Related]
11. Pathology of early hepatocellular carcinoma: progression from early to advanced.
Kojiro M; Yano H; Nakashima O
Semin Surg Oncol; 1996; 12(3):197-203. PubMed ID: 8727611
[TBL] [Abstract][Full Text] [Related]
12. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
13. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
15. Pathology of early hepatocellular carcinoma: progression from early to advanced.
Kojiro M
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375
[TBL] [Abstract][Full Text] [Related]
16. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
17. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
19. 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation.
Kojiro M
Intervirology; 2004; 47(3-5):179-83. PubMed ID: 15383727
[TBL] [Abstract][Full Text] [Related]
20. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma.
Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H
Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
